Japanse Medical Expense Reaches ¥3.4 Trillion; Growth Slows To Below 2 Percent
This article was originally published in PharmAsia News
Japan's Ministry of Health, Labor and Welfare released medical expenses accounting records for FY2008. The combination of national health insurance expenses and medical fees is ¥3.41 trillion, another record number for six years in a row. According to the ministry, the annual growth of the expense in 2008 slowed down to 1.9 percent, compared to a 3.1 percent increase in FY2007. The slow down in growth is a result of a government medical reimbursement change in 2008 that encouraged generic drug substitution. Medical expenses among seniors over 70 years of age accounted for 43.5 percent or ¥1.48 trillion, an increase of 2.1 percent or ¥310 billion. Medical expense per capita is ¥267,000, increased by 1.9 percent or ¥5,000 compared to 2007. (Click here for more - Japanese language
You may also be interested in...
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
BeiGene gets a new chief business executive and there are new CMOs at Cellectar Biopharma, MacroGenics and Reata Pharmaceuticals.
A new EU pilot will help drug regulators and policymakers understand the factors influencing the uneven availability of centrally authorized medicines in the member states.